A Comparison of CT Perfusion Output of RapidAI and Viz.ai Software in the Evaluation of Acute Ischemic Stroke
Authors:
- Saif BushnaqSBSaif Bushnaq
- Ameer E. HassanAHAmeer E. Hassan
- Adam DeloraADAdam Delora
- Ali KerroAKAli Kerro
- Anita DattaADAnita Datta
- Rime EzzeldinRERime Ezzeldin
- Zuhair AliZAZuhair Ali
- Tunmi AnwojuTATunmi Anwoju
- Layla NejadLNLayla Nejad
- Rene SilvaRSRene Silva
- Yazan Diya AbualnadiYAYazan Diya Abualnadi
- Zorain Mustafa KhalilZKZorain Mustafa Khalil
Open Access
- 12 February 2024
- journal article
- research article
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 45 (7) , 863-870
Abstract
BACKGROUND AND PURPOSE: Automated CT Perfusion post-processing packages have been developed for managing acute ischemic stroke (AIS). These packages identify the volume of the ischemic core and penumbra by using advanced image processing techniques. This study aims to investigate the agreement of decision-making rules and output values derived from RapidAI and Viz.ai software packages in early and late time windows and to identify predictors of inadequate quality CT perfusion (CTP) studies. MATERIALS AND METHODS: 129 AIS patients who had CTP performed upon presentation were analyzed. Imaging data were processed by two software packages: RapidAI and Viz.ai. Volumetric outputs were compared between packages by performing Spearman rank-order correlation and Wilcoxon signed-rank tests with sub-analysis performed at early (6 hours) time windows. The concordance of selecting patients based on DAWN and DEFUSE3 eligibility criteria was assessed using Mcnemar test. RESULTS: 108 out of 129 patients were found to have adequate quality studies. Spearman rank-order correlation coefficients were calculated on Tmax >6s volume, Tmax >10s volume, CBF 6s volume, Tmax >10s volume, CBF <30% volume, Mismatch Volume, and Mismatch Ratio with P-Values of 0.30, 0.016, <0.001, 0.03, <0.001 respectively. In a one-sided test, CBF <30% was greater in Viz.ai (p<0.001). Although this resulted in statistically significant differences, it did not cause clinically significant differences when applied to the DAWN and DEFUSE 3 criteria. Lower ejection fraction (EF) predicted an inadequate study in both software packages (P = 0.018; 95% CI: 0.01, 0.113) and (P = 0.024; 95% CI: 0.008, 0.109); for RapidAI and Viz.ai, respectively. In Viz.ai, the presence of a clip, coil, or other metal predicted an inadequate study (P = 0.042; 95% CI: -3.225, -0.057). CONCLUSIONS: Viz.ai predicted higher ischemic core volumes than RapidAI. Viz.ai predicted lower combined core and penumbra values than RapidAI at lower volumes and higher estimates than RapidAI at higher volumes. Clinicians should be cautious when using different software packages for clinical decision-making. ABBREVIATIONS: LVO =Large vessel occlusion; time to maximum peak = Tmax; AIS = acute ischemic stroke; LKW = last known well;Keywords
This publication has 26 references indexed in Scilit:
- Comparison of CT Perfusion Software Packages for Thrombectomy EligibilityAnnals of Neurology, 2023
- Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysisThe Lancet, 2022
- Artificial Intelligence for Large-Vessel Occlusion Stroke: A Systematic ReviewWorld Neurosurgery, 2021
- SciPy 1.0: fundamental algorithms for scientific computing in PythonNature Methods, 2020
- User's guide to correlation coefficientsTurkish Journal of Emergency Medicine, 2018
- Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion ImagingNew England Journal of Medicine, 2018
- Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and InfarctNew England Journal of Medicine, 2018
- Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trialsThe Lancet, 2016
- Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trialThe Lancet Neurology, 2014
- Real‐time diffusion‐perfusion mismatch analysis in acute strokeJournal of Magnetic Resonance Imaging, 2010